Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Ventricular anti-arrhythmic treatments during postinfarction].

R Frank1, J Tonet, G Lascault

  • 1Service de rythmologie et de stimulation cardiaque, hôpital Jean-Rostand, Ivry-sur-Seine.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|November 1, 1992
PubMed
Summary

Antiarrhythmic drugs can increase risks post-heart attack, especially for low-risk patients. Beta-blockers are recommended for high-risk individuals with left ventricular dysfunction to improve outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sudden death during sports activities.

The New England journal of medicine·1995
Same author

[Significance of lymphoplasmocytic infiltration in arrhythmogenic right ventricular dysplasia. Apropos of 3 own cases and review of the literature].

Archives des maladies du coeur et des vaisseaux·1995
Same author

[Outcome of arrhythmogenic right ventricular dysplasia. Apropos of 4 cases].

Archives des maladies du coeur et des vaisseaux·1995
Same author

Arrhythmogenic right ventricular dysplasia/cardiomyopathy: a review.

Pacing and clinical electrophysiology : PACE·1995
Same author

[Fulguration of extrasystolic ventricular focus].

Archivos del Instituto de Cardiologia de Mexico·1995
Same author

Pyridoxine-responsive gyrate atrophy of the choroid and retina: clinical and biochemical correlates of the mutation A226V.

American journal of human genetics·1995

Area of Science:

  • Cardiology
  • Pharmacology

Context:

  • Post-myocardial infarction management.
  • Risk stratification for sudden cardiac death.
  • Treatment of life-threatening arrhythmias.

Purpose:

  • To evaluate the efficacy and safety of antiarrhythmic agents in the post-infarction period.
  • To guide therapeutic choices for preventing sudden death and recurrent arrhythmias.

Summary:

  • Class IC antiarrhythmics may increase risk in low-risk post-infarction patients.
  • Beta-blockers are effective for symptoms and mortality in high-risk patients with left ventricular dysfunction.
  • Amiodarone and beta-blockers are first-line for sustained ventricular tachycardia in patients with ejection fraction < 40%.

Impact:

Related Experiment Videos

  • Informs clinical practice regarding appropriate antiarrhythmic drug selection post-myocardial infarction.
  • Highlights the importance of risk stratification in guiding therapy.
  • Emphasizes the proven efficacy of beta-blockers in high-risk populations.